203 related articles for article (PubMed ID: 35554594)
61. CSF hypocretin measures in patients with obstructive sleep apnea.
Kanbayashi T; Inoue Y; Kawanishi K; Takasaki H; Aizawa R; Takahashi K; Ogawa Y; Abe M; Hishikawa Y; Shimizu T
J Sleep Res; 2003 Dec; 12(4):339-41. PubMed ID: 14633246
[TBL] [Abstract][Full Text] [Related]
62. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
Kubota H; Kanbayashi T; Tanabe Y; Ito M; Takanashi J; Kohno Y; Shimizu T
Sleep; 2003 Aug; 26(5):555-7. PubMed ID: 12938807
[TBL] [Abstract][Full Text] [Related]
63. Diagnostic delay in narcolepsy type 1: combining the patients' and the doctors' perspectives.
Taddei RN; Werth E; Poryazova R; Baumann CR; Valko PO
J Sleep Res; 2016 Dec; 25(6):709-715. PubMed ID: 27149919
[TBL] [Abstract][Full Text] [Related]
64. [NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].
Dauvilliers Y; Lopez R
Rev Prat; 2016 Jun; 66(6):671-6. PubMed ID: 27538328
[TBL] [Abstract][Full Text] [Related]
65. Hypocretin/orexin and narcolepsy: new basic and clinical insights.
Nishino S; Okuro M; Kotorii N; Anegawa E; Ishimaru Y; Matsumura M; Kanbayashi T
Acta Physiol (Oxf); 2010 Mar; 198(3):209-22. PubMed ID: 19555382
[TBL] [Abstract][Full Text] [Related]
66. Nocturnal Sleep Dynamics Identify Narcolepsy Type 1.
Pizza F; Vandi S; Iloti M; Franceschini C; Liguori R; Mignot E; Plazzi G
Sleep; 2015 Aug; 38(8):1277-84. PubMed ID: 25845690
[TBL] [Abstract][Full Text] [Related]
67. Increased immune complexes of hypocretin autoantibodies in narcolepsy.
Deloumeau A; Bayard S; Coquerel Q; Déchelotte P; Bole-Feysot C; Carlander B; Cochen De Cock V; Fetissov SO; Dauvilliers Y
PLoS One; 2010 Oct; 5(10):e13320. PubMed ID: 20967199
[TBL] [Abstract][Full Text] [Related]
68. [Neurophysiological examinations in narcolepsy].
Wierzbicka A; Wichniak A; Czasak K; Musińska I; Jakubczyk T; Sek A; Jernajczyk W
Przegl Lek; 2010; 67(9):726-8. PubMed ID: 21387813
[TBL] [Abstract][Full Text] [Related]
69. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.
Thannickal TC; Nienhuis R; Siegel JM
Sleep; 2009 Aug; 32(8):993-8. PubMed ID: 19725250
[TBL] [Abstract][Full Text] [Related]
70. Daytime sleepiness with and without cataplexy in Chinese-Taiwanese patients.
Huang YS; Tafti M; Guilleminault C
Sleep Med; 2006 Aug; 7(5):454-7. PubMed ID: 16815745
[TBL] [Abstract][Full Text] [Related]
71. Hypocretin and its emerging role as a target for treatment of sleep disorders.
Cao M; Guilleminault C
Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
[TBL] [Abstract][Full Text] [Related]
72. Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.
Baumann CR; Mignot E; Lammers GJ; Overeem S; Arnulf I; Rye D; Dauvilliers Y; Honda M; Owens JA; Plazzi G; Scammell TE
Sleep; 2014 Jun; 37(6):1035-42. PubMed ID: 24882898
[TBL] [Abstract][Full Text] [Related]
73. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
74. Underutilization of the MSLT in sleepy patients with a short onset REM period (SOREMP) in the sleep clinic.
Cairns A; Bogan R
Sleep Med; 2017 Apr; 32():150-156. PubMed ID: 28366327
[TBL] [Abstract][Full Text] [Related]
75. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.
John J; Wu MF; Maidment NT; Lam HA; Boehmer LN; Patton M; Siegel JM
J Physiol; 2004 Oct; 560(Pt 2):587-92. PubMed ID: 15308685
[TBL] [Abstract][Full Text] [Related]
76. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A.
Heier MS; Gautvik KM; Wannag E; Bronder KH; Midtlyng E; Kamaleri Y; Storsaeter J
Sleep Med; 2013 Sep; 14(9):867-71. PubMed ID: 23773727
[TBL] [Abstract][Full Text] [Related]
77. [Narcolepsy with cataplexy].
Dauvilliers Y; Arnulf I
Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
[TBL] [Abstract][Full Text] [Related]
78. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency.
Overeem S; van Nues SJ; van der Zande WL; Donjacour CE; van Mierlo P; Lammers GJ
Sleep Med; 2011 Jan; 12(1):12-8. PubMed ID: 21145280
[TBL] [Abstract][Full Text] [Related]
79. Narcolepsy in Children: Sleep disorders in children, A rapidly evolving field seeking consensus.
Dye TJ; Simakajornboon N
Pediatr Pulmonol; 2022 Aug; 57(8):1952-1962. PubMed ID: 34021733
[TBL] [Abstract][Full Text] [Related]
80. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
